BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//California Life Sciences - ECPv6.16.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.califesciences.org
X-WR-CALDESC:Events for California Life Sciences
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260609T090000
DTEND;TZID=America/Los_Angeles:20260610T160000
DTSTAMP:20260608T203836
CREATED:20260422T182437Z
LAST-MODIFIED:20260422T182507Z
UID:10001070-1780995600-1781107200@www.califesciences.org
SUMMARY:2-Day Hands-on Lyophilization Development & Analysis Workshop
DESCRIPTION:A practical guide to lyophilization formulation\, cycle development and analytical characterization\n\nBook before May 1st and save $500 \n\n2-Day Intensive Laboratory Training | Small Group Format | Certificate of Completion \nThis immersive program guides participants through the complete lyophilization process\, from formulation and thermal analysis to cycle development\, optimization\, and troubleshooting\, in a real working CDMO facility in Carlsbad\, California. Unlike training center environments\, attendees work alongside the same team and equipment used in active commercial production. \nTaught by Dr. Kevin Ward\, R&D Director at Biopharma Group for 26 years and practicing lyophilization since 1993. Kevin and his team have worked on over 5\,000 projects for more than 500 clients across the globe and run more than 400 training courses. \nWhat you’ll learn: \n\nApply thermal characterization (DSC\,impedance analysis) directly to cycle design; understand how to generate and interpret the data necessary to build a stable lyo cycle\nTranslate that analytical data into practical cycle development steps; understand how freezing\, annealing\, primary and secondary drying combine to give you a reliable and consistent end product\nBuild and run freeze-drying cycles based on real-time PAT data\nTroubleshoot problematic cycles with structured strategies such as: What has gone wrong? How do you fix it?\nEvaluate lyophilization cake appearance and identify defects\nPerform post-lyophilization analysis: moisture content\, thermal properties\, mechanical performance\nTransfer cycles between lyophilizers and scaling up from research to production.\n\nThis is a hands-on program\, not a lecture series. Concepts are explored through direct\, practical involvement in our working facility and guided by our expert team every step of the way. Certificate of completion provided. \nView our overview brochure to discover more» \nHosted by:
URL:https://www.califesciences.org/event/hands-on-lyophilization-development-analysis-workshop/
LOCATION:2270 Camino Vida Roble #K\, 2270 Camino Vida Roble #K\, Carlsbad\, CA\, 92104\, United States
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260610T110000
DTEND;TZID=America/Los_Angeles:20260610T140000
DTSTAMP:20260608T203836
CREATED:20260520T223016Z
LAST-MODIFIED:20260520T223016Z
UID:10001089-1781089200-1781100000@www.califesciences.org
SUMMARY:MBC BioLabs Summer Life Science Vendor’s Showcase
DESCRIPTION:Join us for our Summer Life Science Vendor Showcase\, bringing together innovative scientific and business solutions tailored for early-stage biotech teams. Meet industry experts\, explore new technologies\, and discover tools that can accelerate your work at MBC BioLabs. \nWhat to Expect: \n\n​Discover Solutions for Startups — Explore tools and services designed to support drug discovery\, molecular biology\, genomics\, instrumentation\, operational efficiency\, and company growth.\nLunch Included — Pick up your lunch ticket at check-in and enjoy a meal while you explore the showcase.\nMeet New Partners & Build Your Network — Connect with leading vendors who offer cutting-edge technologies and services to strengthen your R&D pipeline.\n\n​This showcase is ideal for: \n\nFounders and early-stage biotech teams\nResearch associates and bench scientists\nPlatform\, screening\, and discovery scientists\n​Operations\, lab managers\, and procurement teams\nAnyone looking to evaluate new tools\, technologies\, or service providers that support R&D and company growth\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/mbc-biolabs-summer-life-science-vendors-showcase/
LOCATION:135 Mississippi St\, 135 Mississippi St\, San Francisco\, CA\, 94118\, United States
CATEGORIES:Industry Collaboration & Networking,Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260610T114500
DTEND;TZID=America/Los_Angeles:20260610T130000
DTSTAMP:20260608T203836
CREATED:20260601T225608Z
LAST-MODIFIED:20260601T225608Z
UID:10001094-1781091900-1781096400@www.califesciences.org
SUMMARY:How to Compete for $4 Billion in Newly Reauthorized SBIR/STTR Funds
DESCRIPTION:The recent reauthorization of the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) program introduces exciting new opportunities along with evolving requirements and shifting priorities. \n​For innovators aiming to compete successfully in this new SBIR/STTR landscape\, a thorough understanding of the reauthorization provisions is essential. \n​Join Eva Garland Consulting’s Scientific Grants Expert\, Dr. Chelcie Heaney\, as she provides a practical overview of the latest SBIR/STTR reauthorization and what it means for applicants targeting the National Institutes of Health and National Science Foundation. Attendees will gain insight into key program updates\, emerging compliance considerations\, and an expert perspective on how to remain competitive in one of the nation’s most valuable non-dilutive funding programs. \n​Lunch will be provided\, and attendees will receive complimentary copies of EGC’s best-selling books on winning SBIR/STTR grants. \n​Agenda: \n\n​11:45 AM – 12:00 PM Arrival and Lunch\n​12:00 PM – 12:30 PM Presentation\n12:30 PM – 1:00 PM Q & A and Networking\n\n​About Dr. Chelcie Heaney: \n​Dr. Heaney is a Senior Scientific Consultant at Eva Garland Consulting. She is an expert in securing non-dilutive funding for life science companies\, with a focus in technology assessment\, product development\, proposal preparation\, gap identification\, and strategic planning. She has contributed to hundreds of grant proposals across Federal Agencies including NIH\, NSF\, DoD\, NASA\, ARPA-H\, and the VA\, helping to secure over $100M in funding for life science companies. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/how-to-compete-for-4-billion-in-newly-reauthorized-sbir-sttr-funds/
LOCATION:University Lab Partners\, 5270 California Ave\, Irvine\, CA\, 92617\, United States
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260610T170000
DTEND;TZID=America/Los_Angeles:20260610T200000
DTSTAMP:20260608T203836
CREATED:20260601T225930Z
LAST-MODIFIED:20260601T225930Z
UID:10001095-1781110800-1781121600@www.califesciences.org
SUMMARY:Beyond the Red Tape: Scaling Connected Health in 2026
DESCRIPTION:As healthcare moves toward proactive\, preventive\, and AI-enabled care models\, the regulatory boundary between “wellness” and “medical device” has been fundamentally redefined. This event brings together leading experts in Regulatory Affairs\, Quality\, Connected Health\, and Digital Health to discuss how organizations can successfully scale connected ecosystems in this new regulatory era. \nKey topics include:\n💡 The 2026 FDA regulatory changes impacting Connected Health and Clinical Decision Support (CDS)\n💡 How companies are navigating the evolving “wellness vs. medical device” boundary\n💡 AI-enabled sensors\, remote monitoring\, and digital health ecosystems\n💡 Using Predetermined Change Control Plans (PCCPs) for AI and software lifecycle management\n💡 Strategies to accelerate innovation while maintaining compliance\n💡 Data validation and regulatory considerations for next-generation connected platforms \n🎤 Featured Speakers:\nRitam Priya — Principal\, Novarum MDRQ Consulting\nWalt Cecka — Medical Technology Fellow\, Triple Ring\nYusi Liu\, RAC.\, SVP of RA and QA\, BioIntelliSense Inc.\nJeanne Zhang\, Principal Regulatory Affairs Specialist\, MiniMed\nAarti Shukla\, M.S.Rsc\, RAC\, Regulatory Affairs\, Roche \n🤝 The evening will also include networking opportunities and an exclusive facility tour of Triple Ring Technologies. \nWhether you work in Regulatory Affairs\, Quality\, Digital Health\, MedTech\, AI\, Software\, or Connected Devices\, this is a conversation you won’t want to miss. \nHosted by:
URL:https://www.califesciences.org/event/beyond-the-red-tape-scaling-connected-health-in-2026/
LOCATION:Triple Ring Technologies\, 39655 Eureka Dr\, Newark\, CA\, 94560\, United States
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260611T084500
DTEND;TZID=America/Los_Angeles:20260611T173000
DTSTAMP:20260608T203836
CREATED:20260506T221126Z
LAST-MODIFIED:20260506T221126Z
UID:10001084-1781167500-1781199000@www.califesciences.org
SUMMARY:Antibody Preclinical Development & IND Filing: Nuts\, Bolts\, Best Practices and Regulatory Strategies
DESCRIPTION:The investigational new drug application (IND) application is an important step in a drug development program\, and understanding the requirements for a successful IND filing is utmost important to ensure fast and efficient development. While the principles and basics are similar across different modalities for an IND filing such as safety studies\, there are important aspects that need to be considered for antibody-based therapeutics (antibodies\, antibody-drug conjugates and multispecific antibodies). In this workshop\, our highly experienced speakers from industry and the FDA will discuss the necessary preclinical studies for an antibody candidate and the best practices and regulatory strategies for a successful IND package of an antibody candidate. \nOutline: \n\nOverview of antibody-based therapeutics: structure\, generation\, design\, and optimization\nOverview of preclinical development and IND filing requirements for antibody-based therapeutics\nNon-clinical pharmacology considerations antibodies and in vivo disease modeling\nPharmacokinetic/Pharmacodynamic and bioanalytical considerations for successful IND filings\nHuman dose projection through clinpharm quantitative modeling\nPreclinical toxicology studies\nIND-enabling CMC activities\nClinical Development Plan\nRegulatory strategies and interactions with FDA: Industry perspective & how to prepare for FDA meetings\nThe regulatory perspective: the do’s and don’ts and avoiding a clinical hold\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/antibody-preclinical-development-ind-filing/
LOCATION:Hilton San Francisco Airport Bayfront\, 600 Airport Blvd\, Burlingame\, CA\, 94010\, United States
CATEGORIES:Industry Events,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260616T100000
DTEND;TZID=America/Los_Angeles:20260616T110000
DTSTAMP:20260608T203836
CREATED:20260526T160015Z
LAST-MODIFIED:20260526T160015Z
UID:10001092-1781604000-1781607600@www.califesciences.org
SUMMARY:Leveraging AI and Research Platforms to Accelerate Next-Generation Biological Modalities
DESCRIPTION:As biologic modalities such as in vivo CAR therapies and antibody-drug conjugates (ADCs) rapidly advance\, the need for efficient and scalable development solutions continues to grow. \nJoin our webinar to explore how AI-enabled protein engineering\, optimized reagents\, and advanced assay platforms can support translational research\, improve reproducibility\, streamline manufacturing\, and accelerate next-generation cancer therapeutics development. \nKey highlights include:\n🔹 AI-powered protein engineering and advanced assay solutions\n🔹 Tools to improve protein interaction studies\, reproducibility\, and translational research\n🔹 Strategies to accelerate next-generation cancer therapeutic development \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/leveraging-ai-and-research-platforms-to-accelerate-next-generation-biological-modalities/
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/leveraging-ai-and-research-platforms-to-accelerate-next-generation-biological-modalities/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260617T090000
DTEND;TZID=America/Los_Angeles:20260617T100000
DTSTAMP:20260608T203836
CREATED:20260603T171823Z
LAST-MODIFIED:20260603T171823Z
UID:10001096-1781686800-1781690400@www.califesciences.org
SUMMARY:From Breakthrough to Bedside: Aligning Regulatory Strategy\, Clinical Evidence and Commercialization in Diagnostics
DESCRIPTION:This panel will examine how diagnostics innovators can effectively move from concept to market adoption. The discussion will cover critical intersections between regulatory strategy\, clinical validation and commercialization\, including FDA pathways\, clinical study design and how to position programs for investment and scale. \nSpeakers include:\n› Sarah Melaney\, Pillsbury Partner (Moderator)\n› Steven Green\, Pillsbury Partner (Panelist)\n› Joen Johansen\, President & CEO of MDC Associates (Panelist)\n› Michele Colucci\, Founding Managing Partner of DigitalDX (Panelist) \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/from-breakthrough-to-bedside-aligning-regulatory-strategy-clinical-evidence-and-commercialization-in-diagnostics/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/from-breakthrough-to-bedside-aligning-regulatory-strategy-clinical-evidence-and-commercialization-in-diagnostics/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260618T073000
DTEND;TZID=America/Los_Angeles:20260618T090000
DTSTAMP:20260608T203836
CREATED:20260520T223208Z
LAST-MODIFIED:20260520T223248Z
UID:10001090-1781767800-1781773200@www.califesciences.org
SUMMARY:Advanced AI for Life Sciences
DESCRIPTION:On June 18th\, Hands On and the Healthcare Businesswomen’s Association are hosting a virtual\, advanced session on AI in Life Sciences. \nHBA and non-HBA members are all welcome to attend. \nAs AI is brought more widely into use\, discover how to adopt and integrate it into your work\, whether you work in R&D\, Tech Ops\, Medical Affairs\, Commercial or G&A. \nFacilitated by an AI expert in life sciences. This session will cover: \n\n\n\nLatest trends in AI\nPragmatic applications\nWhy AI projects succeed and fail\nCurrent AI issues\n\n\n\n\nThe Future of AI\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/advanced-ai-for-life-sciences/
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/advanced-ai-for-life-sciences/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260622
DTEND;VALUE=DATE:20260623
DTSTAMP:20260608T203836
CREATED:20260506T201002Z
LAST-MODIFIED:20260506T201002Z
UID:10001079-1782086400-1782172799@www.califesciences.org
SUMMARY:RESI San Diego
DESCRIPTION:RESI San Diego 2026 will take place on June 22 at the JULEP Venue San Diego during the Convention Week\, followed by FOUR (4) days of virtual partnering on June 23-24\, 29-30. Virtual partnering on the June 29-30 gives you a chance to extend your Convention-week partnering! This hybrid format combines the benefits of in-person networking with the flexibility of online interactions. \n\nCLS members receive a $200 discount on tickets and IPC packages. Contact your account manager or reach out to bd@califesciences.org for more information. \n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/resi-san-diego/
LOCATION:JULEP Venue\, 1735 Hancock St\, San Diego\, CA\, 92101\, United States
CATEGORIES:Industry Collaboration & Networking,Industry Events,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260622
DTEND;VALUE=DATE:20260626
DTSTAMP:20260608T203836
CREATED:20251117T211711Z
LAST-MODIFIED:20260507T160427Z
UID:10000949-1782086400-1782431999@www.califesciences.org
SUMMARY:BIO International Convention 2026
DESCRIPTION:This is the force that unites us—not the pursuit of status or stability\, but the unwavering conviction to solve the impossible\, to push boundaries\, and to achieve better outcomes for patients\, public health\, and the world. \nBIO 2026 is where we return to this essential “why.” It is our opportunity to reconnect as a global community\, to recharge our commitment\, and to remember that behind every innovation is a shared mission: to improve lives. \nConnect with the global biotech community in San Diego June 22-25\, 2026. \nLEARN MORE»
URL:https://www.califesciences.org/event/bio-international-convention-2026/
LOCATION:San Diego Convention Center\, 111 W Harbor Dr\, San Diego\, CA\, 92101\, United States
CATEGORIES:Industry Events
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260623T120000
DTEND;TZID=America/Los_Angeles:20260623T131500
DTSTAMP:20260608T203836
CREATED:20260526T160417Z
LAST-MODIFIED:20260526T160417Z
UID:10001093-1782216000-1782220500@www.califesciences.org
SUMMARY:The AI Data Layer: Building Trust\, Accuracy\, and Scale in Life Sciences
DESCRIPTION:Join Springer Nature for a free lunch event during BIO!\n​As biotech and pharma organizations accelerate adoption of AI across discovery\, R&D\, medical affairs\, and knowledge workflows\, the foundation for success is becoming clear: specialized\, vetted\, and well-structured scientific data underpins the most reliable outcomes and insights from AI systems. \n​Join Dr. Prathik Roy\, Product Director of AIGP Solutions at Springer Nature\, for an exclusive off-site lunch event during the BIO International Convention. The session will explore: \n\n​How semantically enriched scientific content improves downstream AI performance\n​Delivery of scientific data through scalable architectures\, including APIs\, MCP\, and private cloud deployments\n​Approaches for enabling secure\, copyright-cleared enterprise AI applications\n​How trusted scientific literature serves as an integration-ready “data layer” for retrieval-augmented generation (RAG)\, model development\, and agentic AI systems\n​Practical strategies for life sciences organizations to reduce risk in AI implementation\, strengthen the quality of outputs and build trusted infrastructure\n\n​Attendees will gain a candid\, real-world perspective grounded in experience across scientific publishing\, R&D\, and AI-enabled content access. This event is free and lunch will be provided. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/the-ai-data-layer-building-trust-accuracy-and-scale-in-life-sciences/
LOCATION:Huntress\, 376 Fifth Ave\, San Diego\, CA\, 92101\, United States
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260626T084500
DTEND;TZID=America/Los_Angeles:20260626T173000
DTSTAMP:20260608T203836
CREATED:20260506T221429Z
LAST-MODIFIED:20260506T221429Z
UID:10001085-1782463500-1782495000@www.califesciences.org
SUMMARY:Advanced ADME/PK Biopharma LC-MS/MS Method Development Training
DESCRIPTION:This one-day advanced ADME/PK biopharma LC–MS/MS method development training lab course builds on prior mass spectrometry fundamentals with a focus on workflow optimization and practical application on the Sciex platform. The program begins with a recap of prior training and defined learning objectives\, followed by a strategic overview of ADME/PK method development\, including translating project goals into LC–MS/MS workflows\, balancing throughput and data quality\, and selecting between triple quadrupole and HRMS platforms. \nParticipants then rotate through hands-on stations featuring QTRAP and ZenoTOF systems\, covering method setup and submission strategies across multiple acquisition modes. The afternoon sessions focus on data interpretation\, including quantitation using SCIEX-OS\, qualitative versus quantitative workflows\, and instrument readiness. The course concludes with an overview of advanced workflows—such as metabolite identification\, high-throughput analysis\, intact and ICE-IEF approaches\, and biotherapeutics-related methods—followed by closing reflections and discussion of future curriculum topics. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/advanced-adme-pk-biopharma-lc-ms-ms-method-development-training/
LOCATION:SCIEX\, 1201 Radio Road\, Redwood City\, CA\, 94065\, United States
CATEGORIES:Industry Events,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260701T100000
DTEND;TZID=America/New_York:20260701T110000
DTSTAMP:20260608T203836
CREATED:20260511T174029Z
LAST-MODIFIED:20260511T174029Z
UID:10001086-1782900000-1782903600@www.califesciences.org
SUMMARY:Streamlining Nonclinical Development with FDA NAMs
DESCRIPTION:FDA’s draft guidance on the validation of New Approach Methodologies (NAMs) is reshaping how nonclinical programs are designed and justified. This webinar explores how sponsors can apply NAMs to streamline development\, improve human relevance\, and support IND decision-making within a weight-of-evidence framework. \nWe will break down FDA expectations for validation\, including context of use and fit-for-purpose application\, and show how to position NAMs effectively in regulatory interactions. \nThrough real-world case examples spanning in vitro\, in silico\, and data-driven approaches\, attendees will gain practical insight into how NAMs can address data gaps\, reduce reliance on traditional models\, and strengthen nonclinical programs. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/streamlining-nonclinical-development-with-fda-nams/
CATEGORIES:Industry Events
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/streamlining-nonclinical-development-with-fda-nams/
END:VEVENT
END:VCALENDAR